Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma

Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma

User Photo
GiantsOfCancerCare

5 years
587 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jason Luke, MD of the University of Chicago discusses Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma
Up Next Autoplay